|
Sunday, 08/01/2010
|
Bayesian Approach to Noninferiorty Trials for Normal Means
Ram C. Tiwari, FDA
2:05 PM
|
Bayesian Approach to Zero-Inflated Ordered Probit Models
Getachew Dagne, University of South Florida
2:20 PM
|
Estimating Epidemic Parameters of STI Transmission: A Bayesian Approach Using MCMC Techniques
Jeffrey M. Switchenko, Emory University; Lance Waller, Emory University
2:20 PM
|
A Semiparametric Bayesian Approach for Modeling Ordinal Survey Data
Saman Muthukumarana, Simon Fraser University; Tim B. Swartz, Simon Fraser University
2:35 PM
|
Bivariate Semiparametric Bayesian Approach for Finding Minimum Effective Dose and Maximum Safe Dose
Satrajit Roychoudhury, Novartis Pharmaceuticals Corporation; Pulak Ghosh, Indian Institute of Management, Bangalore
2:45 PM
|
Joint Quantile Regression: A Bayesian Approach
Surya Tokdar, Duke University
3:05 PM
|
Multiple Imputation Framework for Combining Data from Multiple Sources
Trivellore Raghunathan, University of Michigan
3:20 PM
|
A Novel Bayesian Approach to Assessing the Risk of QT Prolongation
Suraj Anand, Novartis Pharmaceuticals Corporation; Sujit Kumar Ghosh, North Carolina State University
5:05 PM
|
|
Tuesday, 08/03/2010
|
On Statistical Properties of a Content Validity-Based Bayesian Approach for Validating Measures of Patient-Reported Outcomes
Byron J. Gajewski, The University of Kansas; Valorie Coffland, The University of Kansas School of Nursing; Jamie Leopold, The University of Kansas School of Nursing; Nancy Dunton, The University of Kansas School of Nursing; Diane Boyle, The University of Kansas School of Nursing; Marge Bott, The University of Kansas School of Nursing
8:35 AM
|
A Bayesian Approach to Fitting Mixed Models Using Shape-Restricted Regression Splines
Amber Hackstadt, Colorado State University; Mary Meyer, Colorado State University; Jennifer A. Hoeting, Colorado State University
9:05 AM
|
Application of Bayesian Joint Modeling of Time-to-Event and Patient-Reported Outcomes in an Oncology Clinical Trial
Luping Zhao, Eli Lilly and Company; Wei Shen, Eli Lilly and Company; Haoda Fu, Eli Lilly and Company ; Michelle Denise Hackshaw, Eli Lilly and Company; Mark E. Boye, Eli Lilly and Company
9:15 AM
|
A bayesian approach for detection of multilocus interaction in case control studies
Saonli Basu, University of Minnesota
9:35 AM
|
|
Wednesday, 08/04/2010
|
A Bayesian Approach for Array CGH Segmentation to Assess Chromosomal Aberrations via Gibbs Sampling
Jingjing Ye, Pfizer Inc.; Qiuyan Xu, Travelers Insurance
8:55 AM
|
Stopping Rules for Bayesian Dose-Finding Oncology Trials
Yanqiong Zhang, Sanofi-Aventis; Yi He, sanofi-aventis; Guillaume Marchand, sanofi-aventis; Pierre Mancini, sanofi-aventis; Sandrine Micallef, sanofi-aventis
10:50 AM
|
A Nonparametric Bayesian Approach to Biomarker Discovery
Peter Mueller, MD Anderson Cancer Center; Alejandro Jara, Pontificia Universidad Católica de Chile
11:15 AM
|
A Hybrid Frequentist-Bayesian Approach to a Pilot Study
Nicole Blackman, GlaxoSmithKline
11:55 AM
|
A Homogenous Compound Poisson Change Point Model Approach for the Analysis of CNVs in Genomic Data
Jie Chen, University of Missouri-Kansas City; Ayten Yigiter, Hacettepe University; Hong-Wen Deng, University of Missouri-Kansas City
2:20 PM
|
|